久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • New opioid-alternative raises $3.25 million for Phase I trials firstwordpharma
    January 13, 2019
    AmacaThera, a?Toronto-based company commercializing hydrogel-based drug delivery platforms, has?already?raised?$3.25 million?(CAD) in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners?and welcomes additional investors.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service